Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.
PNK
Unprofitable
Unprofitable
-0.00Â ( -0.37%)
Relative Strenght
Volume Buzz
-98%
Earning Acce
No
Dist 52w H.
4%Quote Panel
Key Metrics
Fundamentals
Relative Strength
MSSTF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.20
N/A
-0.03
vs NA
Q1.21
N/A
-0.02
vs -0.00
Q2.21
N/A
-0.05
vs 0
Q3.21
N/A
-0.09
vs -0.05
Q4.21
N/A
-0.08
vs -0.03
Q1.22
N/A
-0.01
vs -0.02
Q2.22
N/A
-0.01
vs -0.05
Q3.22
N/A
-0.01
vs -0.09
Q4.22
N/A
-0.02
vs -0.08
Q1.23
N/A
-0.03
vs -0.01
Sales Growth
YoY
Current
Estimates
Q4.20
NA
NA vs NA
Q1.21
NA
NA vs NA
Q2.21
NA
NA vs NA
Q3.21
NA
NA vs NA
Q4.21
NA
NA vs NA
Q1.22
NA
2.3M vs NA
Q2.22
NA
1.6M vs NA
Q3.22
NA
1.7M vs NA
Q4.22
NA
2.5M vs NA
Q1.23
-17%
1.9M vs 2.3M
Return on Equity
QoQ
Q2.21
-53%
-0.53
vs -0.43
Q3.21
-126%
-1.26
vs -0.53
Q4.21
-249%
-2.49
vs -1.26
Q1.22
-79%
-0.79
vs -2.49
Q2.22
-37%
-0.37
vs -0.79
Q3.22
-40%
-0.40
vs -0.37
Q4.22
+263%
2.63
vs -0.40
Q1.23
+137%
1.37
vs 2.63
Institutionnal Ownership
newsfilecorp.com
7 hours ago
proactiveinvestors.com
8 hours ago
newsfilecorp.com
17 hours ago
newsfilecorp.com
17 hours ago
newsfilecorp.com
17 hours ago
newsfilecorp.com
18 hours ago
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available